EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Caco-2 Cells, Biopharmaceutics Classification System (BCS) and Biowaiter

Libuše Smetanová, Věra Štětinová, Zbyněk Svoboda, Jaroslav Květina

Acta Medica (Hradec Kralove, Czech Republic) · 2011 · 54 (1) · 3-8

DOI: 10.14712/18059694.2016.9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Medica (Hradec Kralove, Czech Republic), online erschienen am 31.05.2016. Verfasst von Libuše Smetanová und 3 weiteren Autor:innen. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Almost all orally administered drugs are absorbed across the intestinal mucosa. The Caco-2 monolayers are used as an in vitro model to predict drug absorption in humans and to explore mechanism of drug absorption. The Caco-2 cells are derived from a human colon adenocarcinoma and spontaneously differentiate to form confluent monolayer of polarized cells structurally and functionally resembling the small intestinal epithelium. For studying drug permeability, Caco-2 cells are seeded onto the Transwell inserts with semipermeable membrane and grown to late confluence (21 days). After determination of cell viability, the integrity of monolayer is checked by phenol red permeability and by 14 C-mannitol permeability. The transport from apical to basolateral (AP-BL) and basolateral to apical (BL-AP) is studied by adding the diluted drug on the apical or basolateral side and withdrawing the samples from the opposite compartment, respectively, for HPLC analysis or liquid scintillation spectrometry. Ca 2+ - free transport medium is used to determine paracellular component of the drug transport. On the basis of permeability and solubility, drugs can be categorized into four classes of Biopharmaceutics Classification System (BCS). For certain drugs, the BCS-based biowaiver approach can be used which enables to reduce in vivo bioequivalence studies.

Zitieren

APA

Smetanová, L., Štětinová, V., Svoboda, Z., & Květina, J. (2011). Caco-2 Cells, Biopharmaceutics Classification System (BCS) and Biowaiter. Acta Medica (Hradec Kralove, Czech Republic), 54(1), 3-8. https://doi.org/10.14712/18059694.2016.9

Vancouver

Smetanová L, Štětinová V, Svoboda Z, Květina J. Caco-2 Cells, Biopharmaceutics Classification System (BCS) and Biowaiter. Acta Medica (Hradec Kralove, Czech Republic). 2011;54(1):3-8. doi:10.14712/18059694.2016.9

BibTeX
@article{Smetanov2011,
  author = {Smetanová, Libuše and Štětinová, Věra and Svoboda, Zbyněk and Květina, Jaroslav},
  title = {Caco-2 Cells, Biopharmaceutics Classification System (BCS) and Biowaiter},
  journal = {Acta Medica (Hradec Kralove, Czech Republic)},
  year = {2011},
  volume = {54},
  number = {1},
  pages = {3--8},
  doi = {10.14712/18059694.2016.9}
}
Kostenlos starten →